                         SEQUENCE LISTING

<110>  INOVIO PHARMACEUTICALS, INC
       YAN, Jian
       SLAGER, Anna
       GARMAN, Bradley
       COOCH, Neil
 
<120>  CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF

<130>  104409.000448 / INO-1004 WO

<150>  US 62/598,267

<151>  2017-12-13

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  483
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Consensus Survivin isoform 1 DNA Coding Sequence pGX1428

<400>  1
atggattgga cctggattct gttcctggtg gcagcagcaa cccgggtgca ctccggagcc       60

cccacactgc cccctgcctg gcagctgttt ctgaaggacc acaggatctc tacattcaag      120

aactggccct ttctggaggg atgcgcatgt gcacctgaga ggatggcaga ggcaggcttc      180

atccactgcc ctgccgagaa tgagccagat ctggcccagt gcttcttttg ttttaaggag      240

ctggagggct gggagccaga cgatgacccc atcgaggagc acaagaagca cagctccggc      300

gccgccttcc tgtctgtgaa gaagcagttt gaggagctga ccctgagcga gttcctgaag      360

ctggatcggg agagagccaa gaacaagatc gccaaggaga ccaacaacaa gaagaaggag      420

tttgaggaga cagccaagaa ggtgaggtgt gccatcgagc agctggccgc catggactga      480

taa                                                                    483


<210>  2
<211>  159
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Consensus Survivin isoform 1 Protein Coding Sequence pGX1428

<400>  2

Met Asp Trp Thr Trp Ile Leu Phe Leu Val Ala Ala Ala Thr Arg Val 
1               5                   10                  15      


His Ser Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Leu Phe Leu Lys 
            20                  25                  30          


Asp His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys 
        35                  40                  45              


Ala Cys Ala Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro 
    50                  55                  60                  


Ala Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu 
65                  70                  75                  80  


Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys 
                85                  90                  95      


His Ser Ser Gly Ala Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu 
            100                 105                 110         


Leu Thr Leu Ser Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn 
        115                 120                 125             


Lys Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr 
    130                 135                 140                 


Ala Lys Lys Val Arg Cys Ala Ile Glu Gln Leu Ala Ala Met Asp 
145                 150                 155                 


<210>  3
<211>  696
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Consensus Survivin isoform 1 + isoform 3 truncated DNA Coding 
       Sequence pGX1429

<400>  3
atggattgga catggattct gttcctggtg gcagcagcaa ccagggtgca ctctggagca       60

ccaacactgc cccctgcatg gcagctgttt ctgaaggacc accggatcag caccttcaag      120

aactggcctt ttctggaggg ctgcgcctgt gccccagaga gaatggcaga ggcaggcttc      180

atccactgcc cagccgagaa tgagcctgat ctggcccagt gcttcttttg ttttaaggag      240

ctggagggct gggagcctga cgatgaccca atcgaggagc acaagaagca cagctccgga      300

gcagccttcc tgagcgtgaa gaagcagttt gaggagctga cactgtccga gttcctgaag      360

ctggataggg agcgcgccaa gaacaagatc gccaaggaga ccaacaacaa gaagaaggag      420

tttgaggaga cagccaagaa ggtgcggtgt gcaatcgagc agctggcagc aatggacagg      480

ggaagaaagc ggagatccat gcagaggaag cctaccatca ggcgcaagaa tctgcgcaag      540

ctgcggagaa agtgcgccgt gccatctagc tcctggctgc cctggacaga ggcctctggc      600

tggagctgtc tggtgcccga gtggctgcac cacttccagg gactgtttcc tggagccacc      660

tccctgccag tgggaccact ggccatgtct tgataa                                696


<210>  4
<211>  210
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Consensus Survivin isoform 1 + isoform 3 truncated Protein Coding 
       Sequence pGX1429

<400>  4

Met Asp Trp Thr Trp Ile Leu Phe Leu Val Ala Ala Ala Thr Arg Val 
1               5                   10                  15      


His Ser Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Leu Phe Leu Lys 
            20                  25                  30          


Asp His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys 
        35                  40                  45              


Ala Cys Ala Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro 
    50                  55                  60                  


Ala Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu 
65                  70                  75                  80  


Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys 
                85                  90                  95      


His Ser Ser Gly Ala Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu 
            100                 105                 110         


Leu Thr Leu Ser Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn 
        115                 120                 125             


Lys Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr 
    130                 135                 140                 


Ala Lys Lys Val Arg Cys Ala Ile Glu Gln Leu Ala Ala Met Asp Arg 
145                 150                 155                 160 


Gly Arg Lys Arg Arg Ser Met Gln Arg Lys Pro Thr Ile Arg Arg Lys 
                165                 170                 175     


Asn Leu Arg Lys Leu Arg Arg Lys Cys Ala Val Pro Ser Ser Ser Trp 
            180                 185                 190         


Leu Pro Trp Thr Glu Ala Ser Gly Trp Ser Cys Leu Val Pro Glu Trp 
        195                 200                 205             


Leu His 
    210 


<210>  5
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  matrix pools 1, 2, 3, 4, and 7

<400>  5

Leu Pro Pro Ala Trp Gln Leu Phe Leu Lys Asp His Arg Ile Ser Thr 
1               5                   10                  15      


Phe Lys Asn 
            


<210>  6
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  matrix pools 1, 2, 3, 4 and 11

<400>  6

Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys Ile Ala Lys Glu Thr 
1               5                   10                  15      


Asn Asn Lys 
            


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  matrix pools 3, 4 and 7

<400>  7

Glu Trp Leu His His Phe Gln Gly Leu Phe Pro 
1               5                   10      



<210>  8
<211>  232
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Consensus Survivin isoform 1 + isoform 3 truncated Protein Coding 
       Sequence pGX1429 Full Length

<400>  8

Met Asp Trp Thr Trp Ile Leu Phe Leu Val Ala Ala Ala Thr Arg Val 
1               5                   10                  15      


His Ser Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Leu Phe Leu Lys 
            20                  25                  30          


Asp His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys 
        35                  40                  45              


Ala Cys Ala Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro 
    50                  55                  60                  


Ala Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu 
65                  70                  75                  80  


Leu Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys 
                85                  90                  95      


His Ser Ser Gly Ala Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu 
            100                 105                 110         


Leu Thr Leu Ser Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn 
        115                 120                 125             


Lys Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr 
    130                 135                 140                 


Ala Lys Lys Val Arg Cys Ala Ile Glu Gln Leu Ala Ala Met Asp Arg 
145                 150                 155                 160 


Gly Arg Lys Arg Arg Ser Met Gln Arg Lys Pro Thr Ile Arg Arg Lys 
                165                 170                 175     


Asn Leu Arg Lys Leu Arg Arg Lys Cys Ala Val Pro Ser Ser Ser Trp 
            180                 185                 190         


Leu Pro Trp Thr Glu Ala Ser Gly Trp Ser Cys Leu Val Pro Glu Trp 
        195                 200                 205             


Leu His His Phe Gln Gly Leu Phe Pro Gly Ala Thr Ser Leu Pro Val
    210                 215                 220


Gly Pro Leu Ala Met Glu Thr Ser
225                 230